Search

You searched for "inflammation"

1533 results found

100% Optical wins ‘best brand collaboration’ accolade

26 September 2023 | AOP, 100% Optical, Media 10, Awards
Optical tradeshow won the ‘Best Brand Collaboration’ award at the Exhibition News Indy Awards for the Association of Optometrists’ (AOP) partnership with Media 10.

Part 1: Her Royal Highness The Duchess of Edinburgh Visits Ethiopia with Orbis

13 October 2023 | Ethiopia, Orbis, HRH, Charity, Highness, Duchess, IAPB
Her Royal Highness The Duchess of Edinburgh, visited services protecting the vision of children and adults in Hawassa, Ethiopia, with international eyecare charity Orbis.

Fingolimod: ocular adverse effects

1 October 2017 | | Retina / Uvea / Vitreous
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....

High dose (2.5mg) bevacizumab for postradiation cystoid macular oedema

1 April 2017 | | Ocular Pathology and Oncology | Anti-VEGF, Cystoid macular edema, Melanoma, Radiation damage, Radiotherapy, Tumor
The authors present a retrospective, interventional case series investigating the efficacy of high dose (2.5mg/0.1ml) intravitreal bevacizumab in the treatment of persistent postradiation (Iodine-125 plaque brachytherapy for uveal melanoma) cystoid macular oedema (CME). Persistent CME was defined as increased or...

Bookings open for education programme at 100% Optical

16 January 2024 | 100%, ophthalmology, education, programme, events, Conferences
100% Optical releases suite of education for event that will take place from 24-26 February at ExCeL London.

Rayner announces acquisition of Sophi

17 January 2024 | Contracts & Distributors, Company Profiles
Rayner, a global leader in products for cataract surgery headquartered in Worthing, UK, announced today (17 January 2024) that it has entered into a definitive agreement to acquire Swiss-based This AG, the inventor, developer and manufacturer of Sophi phaco emulsification machines.

WE KNOW THAT YOU ARE MORE THAN MEETS THE EYE

23 January 2024 | Sight Scotland, Charity, Campaign, Awareness, sight impairment
Charity’s new campaign aims to dispel negative perceptions of people living with sight loss.

SPOKE launches Project Four Supervision Guidance

31 January 2024 | optometry, optometrist, guidance, GOC, AHP, allied health professions
The Sector Partnership for Optical Knowledge and Education (SPOKE) has published the output of its fourth project.

Study calls for thorough investigation of patients with early signs of retinal vascular disease

2 February 2024 | Paracentral acute middle maculopathy, PAMM, moorfields, research, oculomics
Patients with the eye condition Paracentral Acute Middle Maculopathy (PAMM) would benefit from further investigation, as their risk of heart attacks and strokes may be greater than previously shown, suggests a new study led by researchers at Moorfields Eye Hospital NHS Foundation Trust.

Children and Young People’s Commissioner commends Sight Scotland for leading the way in inclusive education

5 February 2024 | Sight Scotland, Royal Blind School, Edinburgh, Scotland, visual impairment, children, young people, charity
Nicola Killean, Children and Young People’s Commissioner Scotland, has praised Sight Scotland for not only upholding the rights of visually impaired children and young people, but also empowering them to know their own rights so they can shape their own educational journey.

Nominations open for AOP elected and designated Council positions

15 February 2024 | council, infrastructure, AOP, nominations, optometry
The Association of Optometrists invites nominations from eligible members for its 2024 Council elections.

SPOKE launches Indicative Guidance for contact lens opticians and independent prescribers

20 February 2024 | GOC, ABDO, Optometrist, education
The Sector Partnership for Optical Knowledge and Education (SPOKE) has published two new Indicative Guidance documents.